Analysis of Transduction Efficiency, Tropism and Axonal Transport of AAV Serotypes 1, 2, 5, 6, 8 and 9 in the Mouse Brain
Open accessThe DOI matches its Crossref record; 68 of the 68 references it cites were found in a registry or an index.
Abstract
Recombinant Adeno-associated virus vectors (rAAV) are widely used for gene delivery and multiple naturally occurring serotypes have been harnessed to target cells in different tissues and organs including the brain. Here, we provide a detailed and quantitative analysis of the transduction profiles of rAAV vectors based on six of the most commonly used serotypes (AAV1, AAV2, AAV5, AAV6, AAV8, AAV9) that allows systematic comparison and selection of the optimal vector for a specific application. In our studies we observed marked differences among serotypes in the efficiency to transduce three different brain regions namely the striatum, hippocampus and neocortex of the mouse. Despite the fact that the analyzed serotypes have the general ability to transduce all major cell types in the brain (neurons, microglia, astrocytes and oligodendrocytes), the expression level of a reporter gene driven from a ubiquitous promoter varies significantly for specific cell type / serotype combinations. For example, rAAV8 is particularly efficient to drive transgene expression in astrocytes while rAAV9 appears well suited for the transduction of cortical neurons. Interestingly, we demonstrate selective retrograde transport of rAAV5 along axons projecting from the ventral part of the entorhinal cortex to the dentate gyrus. Furthermore, we show that self-complementing rAAV can be used to significantly decrease the time required for the onset of transgene expression in the mouse brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“AAV5 transduces only granular cells”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [69]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe cited source doesn’t support the claim as written.
In the citing paper
“AAV2 is restricted to pyramidal and granular cells”
From AAVrh.10-Mediated APOE2 Central Nervous System Gene Therapy for APOE4-Associated Alzheimer's Disease (2018) · cites this paper as [69]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“They express the transgene within days or weeks and can reach full expression levels after 4-6 weeks in vivo [20,21].”
From Recombinant Adeno-Associated Viral Vectors (rAAV)-Vector Elements in Ocular Gene Therapy Clinical Trials and Transgene Expression and Bioactivity Assays (2020) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“While the promoter was cytomegalovirus (CMV), AAV9 has robust tropism for neurons and displays high expression levels in the hippocampus (Aschauer et al., 2013).”
From Hippocampal TMEM55B overexpression in the 5XFAD mouse model of Alzheimer's disease (2024) · cites this paper as Aschauer et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Place navigation impaired in rats with hippocampal lesions
Morris, R. G. M., Garrud, P., Rawlins, J. N. P., & O'Keefe, J. (1982) · Nature · doi:10.1038/297681a0 · Cited by 6,340 · cited 1×
“We choose the hippocampus as this is an intensely studied brain region for its role in memory formation and spatial navigation [20], the striatum for its role in the coordination of movements and neurological diseases such as Parkinson’s disease [21,22] and finally the neocortex as the part of the brain specific to ma…”
Genome-wide atlas of gene expression in the adult mouse brain
Lein, E. S., Hawrylycz, M. J., Ao, N., Ayres, M., Bensinger, A., Bernard, A., Boe, A. F., Boguski, M. S., Brockway, K. S., Byrnes, E. J., et al. (2007) · Nature · doi:10.1038/nature05453 · Cited by 5,572 · cited 1×
“However, in situ expression data does not indicate selective expression of PDGFR alpha or beta in the entorhinal cortex that could explain specific retrograde labeling of entorhinal neurons in a simple manner [67].”
BackgroundInterneurons of the neocortical inhibitory system
Markram, H., Toledo-Rodriguez, M., Wang, Y., Gupta, A., Silberberg, G., & Wu, C. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1519 · Cited by 2,954 · cited 1×
“We chose gamma-aminobutyric acid (GABA) as a marker for the major population of inhibitory neurons in the central brain [27], oligodendrocyte transcription factor 2 (Olig2) as a marker for oligodendrocytes [28], ionized calcium-binding adapter molecule 1 (Iba1) as a marker for microglia [29] and glial fibrillary acidi…”
MethodA resource of Cre driver lines for genetic targeting of GABAergic neurons in cerebral cortex
Taniguchi, H., He, M., Wu, P., Kim, S., Paik, R., Sugino, K., Kvitsani, D., Fu, Y., Lu, J., Lin, Y., et al. (2011) · Neuron · doi:10.1016/j.neuron.2011.07.026 · Cited by 1,828 · cited 2×
“To determine what population of long-range projecting neurons is selectively labeled by AAV5 we performed injections of rAAV5 in a transgenic mouse strain in which GABA-ergic interneurons are labeled by the red fluorescent reporter protein tdTomato [26,50].”
BackgroundMethodLearning and Memory Functions of the Basal Ganglia
Packard, M. G., & Knowlton, B. J. (2002) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.25.112701.142937 · Cited by 1,717 · cited 1×
“We choose the hippocampus as this is an intensely studied brain region for its role in memory formation and spatial navigation [20], the striatum for its role in the coordination of movements and neurological diseases such as Parkinson’s disease [21,22] and finally the neocortex as the part of the brain specific to ma…”
Analysis of AAV Serotypes 1–9 Mediated Gene Expression and Tropism in Mice After Systemic Injection
Zincarelli, C., Soltys, S., Rengo, G., & Rabinowitz, J. E. (2008) · Molecular Therapy · doi:10.1038/mt.2008.76 · Cited by 1,490 · cited 3×
“Indeed, significant differences in transduction efficacy of various serotypes for particular tissues and cell types have been described [11,12,16-19].”
BackgroundAmygdala circuitry mediating reversible and bidirectional control of anxiety
Tye, K. M., Prakash, R., Kim, S.-Y., Fenno, L. E., Grosenick, L., Zarabi, H., Thompson, K. R., Gradinaru, V., Ramakrishnan, C., & Deisseroth, K. (2011) · Nature · doi:10.1038/nature09820 · Cited by 1,289 · cited 1×
“In recent years many studies have taken advantage of recombinant viral vectors derived from Adeno-associated virus (AAV) as a gene delivery tool [3-5].”
BackgroundInduction of neurogenesis in the neocortex of adult mice
Magavi, S. S., Leavitt, B. R., & Macklis, J. D. (2000) · Nature · doi:10.1038/35016083 · Cited by 1,216 · cited 1×
“In addition, all sections were stained with the pan-neuronal marker neuronal nuclei (NeuN) [31] and the DNA stain DAPI that highlights nuclei.”
Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs
Olson, J. K., & Miller, S. D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.6.3916 · Cited by 1,215 · cited 1×
“This stimulus is known to induce an acute inflammatory response [36] and shows that our protocol to detect microglia is sensitive to tissue undergoing an immune reaction and that this reaction is limited locally to one hemisphere (Figure 4).”
BackgroundMonosynaptic Restriction of Transsynaptic Tracing from Single, Genetically Targeted Neurons
Wickersham, I. R., Lyon, D. C., Barnard, R. J. O., Mori, T., Finke, S., Conzelmann, K.-K., Young, J. A. T., & Callaway, E. M. (2007) · Neuron · doi:10.1016/j.neuron.2007.01.033 · Cited by 1,187
Cited by
Items 201–300 of 557
Ascl1 phospho-site mutations enhance neuronal conversion of adult cortical astrocytes in vivo
Ghazale, H., Park, E., Vasan, L., Mester, J. R., Saleh, F., Trevisiol, A., Zinyk, D. L., Chinchalongporn, V., Liu, M., Fleming, T., et al. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.917071 · Cited by 27
“both been reported to transduce cortical astrocytes (Aschauer et al., 2013), and using a 681bp human gfaABC(1)D promoter (Lee et al.”
BackgroundJang, M.-S., Lee, S. E., & Cho, I. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00157 · Cited by 18
“Other serotypes, such as AAV-DJ, are potentially useful but have been less well examined (Cearley and Wolfe, 2006; Klein et al., 2008; Aschauer et al., 2013; Holehonnur et al., 2014).”
BackgroundMehlman, M. L., Winter, S. S., Valério, S., & Taube, J. S. (2018) · Journal of Neurophysiology · doi:10.1152/jn.00143.2018 · Cited by 26
Kobayashi, M., Benakis, C., Anderson, C. J., Moore, M. J., Poon, C., Uekawa, K., Dyke, J. P., Fak, J. J., Mele, A., Park, C. Y., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.075 · Cited by 26
Functional roles of ST8SIA3-mediated sialylation of striatal dopamine D2 and adenosine A2A receptors
Lin, C., Lai, H., Chen, H., Siew, J. J., Hsiao, C.-T., Chang, H.-C., Liao, K., Tsai, S.-C., Wu, C., Kitajima, K., et al. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0529-z · Cited by 26
Noftz, W. A., Beebe, N. L., Mellott, J. G., & Schofield, B. R. (2020) · Frontiers in Neural Circuits · doi:10.3389/fncir.2020.00043 · Cited by 27
“The two vectors used here were serotype 2, selected because of relatively high efficiency in anterograde labeling of neuronal pathways (Aschauer et al., 2013; Salegio et al., 2013).”
MethodWang, J., & Zhang, L. (2021) · Microbes and infection · doi:10.1016/j.micinf.2021.104829 · Cited by 23
RNAi-Based GluN3A Silencing Prevents and Reverses Disease Phenotypes Induced by Mutant huntingtin
Marco, S., Murillo, A., & Pérez‐Otaño, I. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.013 · Cited by 28
“Serotypes 8, 9, and 10 were chosen based on previous reports.(23,24) Viral particles were delivered into the striatum using coordinates determined with the Paxinos”
MethodLive-Animal Epigenome Editing: Convergence of Novel Techniques
Gomez, J. A., Beitnere, U., & Segal, D. J. (2019) · Trends in Genetics · doi:10.1016/j.tig.2019.04.007 · Cited by 24
“effective for transducing cortical neurons, whereas AAV8 is more efficient for transduction in astrocytes [25].”
BackgroundCanine Adenovirus 2: A Natural Choice for Brain Circuit Dissection
Lavoie, A., & Liu, B. (2020) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2020.00009 · Cited by 26
Kitanishi, T., Tashiro, M., Kitanishi, N., & Mizuseki, K. (2022) · Communications Biology · doi:10.1038/s42003-022-03096-3 · Cited by 29
Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology
Sizemore, R. J., Seeger-Armbruster, S., Hughes, S. M., & Parr‐Brownlie, L. C. (2016) · Journal of Neurophysiology · doi:10.1152/jn.01131.2015 · Cited by 27
“AAV5 is a retrograde tracer in some situations (Aschauer et al. 2013), although it is mainly restricted to the site of injection within the BG with anterograde spread of the transgene-encoded protein (Salegio et al. 2013).”
BackgroundSun, S., & Schaffer, D. V. (2018) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2017.12.011 · Cited by 24
AAV-vector based gene therapy for mitochondrial disease: progress and future perspectives
Hanaford, A. R., Cho, Y., & Nakai, H. (2022) · Orphanet Journal of Rare Diseases · doi:10.1186/s13023-022-02324-7 · Cited by 25
“Of the most commonly discussed serotypes in this review, AAV9 can cross the blood–brain barrier and transduce a variety of cell types found in the central nervous system (CNS) [17], AAV8 shows high tropism for hepatocytes [18], and AAV2 tropism is broad.”
BackgroundInfluentialHowell, C. J., Sceniak, M. P., Lang, M., Krakowiecki, W., Abouelsoud, F. E., Lad, S. U., Yu, H., & Katz, D. M. (2017) · eneuro · doi:10.1523/eneuro.0277-17.2017 · Cited by 23
“Consistent with previous evidence that AAV8 is not transported either transynaptically or in the retrograde direction (Aschauer et al., 2013), we found no cell bodies labeled with DREADD-Gq outside of the regions mentioned above.”
Simple and highly specific targeting of resident microglia with adeno‐associated virus
Serrano, C., Cananzi, S., Shen, T., Wang, L.-L., & Zhang, C.-L. (2024) · iScience · doi:10.1016/j.isci.2024.110706 · Cited by 23
“15,41 To reduce non-specific transgene expression in neurons, we inserted into the AAV vector with 4 copies of the target sequence of miR124 , a microRNA highly enriched in neurons.”
Revolution of AAV in Drug Discovery: From Delivery System to Clinical Application
Yin, L., He, H., Zhang, H., Shang, Y., Fu, C., Wu, S., & Jin, T. (2025) · Journal of Medical Virology · doi:10.1002/jmv.70447 · Cited by 27
“As promising vectors for the lysosomal enzyme arylsulfatase A (ARSA) delivery, AAVs can trans ‐ synaptically transduce neurons through anterograde transport by AAV ‐ 1, 2, 5, 6 rather than AAV ‐ 8, 9 [316, 317].”
Therapeutic application of the CRISPR system: current issues and new prospects
Lee, M., & Kim, S. (2019) · Human Genetics · doi:10.1007/s00439-019-02028-2 · Cited by 25
Watakabe, A., Sadakane, O., Hata, K., Ohtsuka, M., Takaji, M., & Yamamori, T. (2016) · Developmental Neurobiology · doi:10.1002/dneu.22459 · Cited by 25
“For example, we and others found glial expression of the CMV promoter for AAV8 and AAV9, whereas others reported neuronal tropism for these serotypes (Masamizu et al. 2011; Aschauer et al., 2013; Scheyltjens et al., 2015).”
BackgroundGünther, A., Luczak, V., Abel, T. G., & Baumann, A. (2017) · Journal of Experimental Biology · doi:10.1242/jeb.154583 · Cited by 24
“As AAV9 is known to transduce neurons as well as astrocytes (Aschauer et al., 2013), we cannot rule out that constitutive shRNA expression in astrocytes might be an additional factor in the observed hippocampal degeneration.”
BackgroundOptogenetic stimulation: Understanding memory and treating deficits
Barnett, S. C., Perry, B. A. L., Dalrymple‐Alford, J. C., & Parr‐Brownlie, L. C. (2018) · Hippocampus · doi:10.1002/hipo.22960 · Cited by 27
Evaluation of WGA–Cre-dependent topological transgene expression in the rodent brain
Libbrecht, S., den Haute, C. V., Malinouskaya, L., Gijsbers, R., & Baekelandt, V. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1241-x · Cited by 30
“Since this characteristic seems to depend upon the serotype and the region of interest, retrograde transfer could be limited by the use of the right serotype for the application (Aschauer et al. 2013; Cearley and Wolfe 2006; Van der Perren et al. 2011; Taymans et al. 2007).”
BackgroundResultBaleisyte, A., Schneggenburger, R., & Kochubey, O. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.110850 · Cited by 24
“This finding was different from previous findings in cortical neurons, in which the transduction efficiency of AAV8 was higher than that of AAV2 (Aschauer et al., 2013; Watakabe et al., 2015).”
ResultGene therapy and kidney diseases
Tavakolidakhrabadi, N., Ding, W. Y., Saleem, M. A., Welsh, G. I., & May, C. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101333 · Cited by 30
Use of Adeno‐Associated and Herpes Simplex Viral Vectors for In Vivo Neuronal Expression in Mice
Penrod, R. D., Wells, A. M., Carlezon, W. A., & Cowan, C. W. (2015) · Current Protocols in Neuroscience · doi:10.1002/0471142301.ns0437s73 · Cited by 23
“…−4.75b 15 Glass pipet recommended Makoto Taniguchi Prelimbic prefrontal cortex +1.8 ±0.4 −1.5c 0 AAV5 Yan Li Striatum +0.9 ±1.5 −3.2b 0 AAVs 1, 2, 5, 6, 8, 9 with differential spread Aschauer et al. (2013) Thalamus—motor −0.45 ±0.85 −3.25d 0 AAV2/1 Hooks et al. (2013) Thalamus—sensory −1.2…”
BackgroundInfluentialGenetic Constructs for the Control of Astrocytes’ Activity
Borodinova, A. A., Balaban, P. M., Борисович, Б. И., Salmina, A. B., & Власова, О. Л. (2021) · Cells · doi:10.3390/cells10071600 · Cited by 24
“Aschauer and colleagues provided in-depth in vivo screening of a set of recombinant AAVs (AAV1, 2, 5, 6, 8, 9) for four cell types (neurons, microglia, astrocytes, oligodendrocytes) in three different regions of the mouse brain [61].”
BackgroundNotch1 activity in the olfactory bulb is odour‐dependent and contributes to olfactory behaviour
Brai, E., Marathe, S. V., Zentilin, L., Giacca, M., Nimpf, J., Kretz, R., Scotti, A. L., & Alberi, L. A. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12719 · Cited by 24
Lin, P., Fang, Z., Liu, J., & Lee, J. H. (2016) · Journal of Visualized Experiments · doi:10.3791/53346 · Cited by 24
Hashimoto, H., Mizushima, T., Chijiwa, T., Nakamura, M., & Suemizu, H. (2017) · Virus Research · doi:10.1016/j.virusres.2017.05.017 · Cited by 21
Zhuang, X., Huang, L., Gu, Y., Wang, L., Zhang, R., Zhang, M., Li, F. Y., Shi, Y., Mo, Y., Dai, Q., et al. (2019) · Archives of Medical Science · doi:10.5114/aoms.2019.85202 · Cited by 25
“0) expression in the central nervous system in mice, we used adeno-associated virus (AAV)2/9 as a vector [30] and the calcium-calm-”
MethodChapdelaine, P., Gérard, C., Sanchez, N., Cherif, K., Rousseau, J., Ouellet, D. L., Jauvin, D., & Tremblay, J. P. (2016) · Gene Therapy · doi:10.1038/gt.2016.36 · Cited by 24
Pommer, S., Akamine, Y., Schiffmann, S. N., d’Exaerde, A. D. K., & Wickens, J. R. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.1037-20.2021 · Cited by 22
“Serotype 5 provided high neuronal 117 and low transynaptic infection (Zincarelli et al., 2008; Aschauer et al., 2013).”
BackgroundChandran, J. S., Chowdhury, E. A., Perkinton, M. S., Jamier, T., Sutton, D., Wu, S., Dobson, C., Shah, D. K., Chessell, I. P., & Meno‐Tetang, G. M. L. (2022) · Gene Therapy · doi:10.1038/s41434-022-00346-1 · Cited by 20
“which has been shown to have a different cellular tropism to AAV9 in the rodent brain [27, 28].”
BackgroundEngeln, M., Fox, M. E., Chandra, R., Choi, E. Y., Nam, H., Qadir, H., Thomas, S., Rhodes, V. M., Turner, M. D., Herman, R. J., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01668-7 · Cited by 22
“Circuitspecific viral expression was achieved using the retrograde properties of adeno-associated virus (AAV) serotype 5 [23]: AAV5.”
MethodChan, Y.-C., Kienle, E., Oti, M., Liddo, A. D., Méndez-Lago, M., Aschauer, D. F., Peter, M., Pagani, M., Arnold, C. D., Vonderheit, A., et al. (2023) · Scientific Reports · doi:10.1038/s41598-023-33448-w · Cited by 25
Self-citationSafety and Efficacy of Intravenous and Intrathecal Delivery of AAV9-Mediated ARSA in Minipigs
Mullagulova, A., Shaimardanova, A., Solovyeva, V., Mukhamedshina, Y., Chulpanova, D., Kostennikov, A., Issa, S. S., & Rizvanov, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119204 · Cited by 21
“Among new AAV serotypes, AAVrh.10, isolated from non-human primates, migrated more efficiently from the intracerebral site compared to AAV1, AAV2, AAV5, AAV7, or AAV8 [39,40].”
BackgroundGenetic manipulation of specific neural circuits by use of a viral vector system
Kobayashi, K., Kato, S., & Kobayashi, K. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1674-7 · Cited by 22
In vivo dynamics of AAV-mediated gene delivery to sensory neurons of the trigeminal ganglia
Dang, C. H., Aubert, M., Feelixge, H. S. D. S., Diem, K., Loprieno, M. A., Roychoudhury, P., Stone, D., & Jerome, K. R. (2017) · Scientific Reports · doi:10.1038/s41598-017-01004-y · Cited by 22
Hodgetts, S., Yoon, J. H., Fogliani, A., Akinpelu, E. A., Baron-Heeris, D., Houwers, I. G. J., Wheeler, L. P. G., Majda, B., Santhakumar, S., Lovett, S. J., et al. (2018) · Journal of Neural Transplantation and Plasticity · doi:10.1155/2018/9828725 · Cited by 16
“Most importantly there is now clear evidence in human postmortem material that there is long-term survival of CSN after SCI [23], making strategies that target these neurons of genuine clinical relevance, potentially in both acute and chronic circumstances.”
MethodInfluentialWang, J., Sun, P., Lv, X., Jin, S., Li, A., Kuang, J., Li, N., Gang, Y., Guo, R. M., Zeng, S., et al. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00616-1 · Cited by 22
Retrograde capabilities of adeno-associated virus vectors in the central nervous system
Surdyka, M., & Figiel, M. (2021) · Biotechnologia · doi:10.5114/bta.2021.111111 · Cited by 24
“Aschauer et al. (2013) examined the transport of rAAV serotypes in the CNS.”
BackgroundThe role of the gustatory cortex in incidental experience-evoked enhancement of later taste learning
Flores, V. L., Parmet, T., Mukherjee, N., Nelson, S. B., Katz, D. B., & Levitan, D. (2018) · Learning & Memory · doi:10.1101/lm.048181.118 · Cited by 24
“This AAV serotype has been shown to effectively spread and infect all cell types (Aschauer et al. 2013), and to be effective within GC (Maier et al. 2015; Li et al. 2016).”
BackgroundAdvances in Recombinant Adeno-Associated Virus Vectors for Neurodegenerative Diseases
Li, L., Vasan, L., Kartono, B., Clifford, K. P., Attarpour, A., Sharma, R., Mandrozos, M., Kim, A., Zhao, W., Belotserkovsky, A., et al. (2023) · Biomedicines · doi:10.3390/biomedicines11102725 · Cited by 20
“Early attempts to identify AAVs for brain applications were based on the identification of serotypes that naturally target the brain [50,51].”
BackgroundJin, L., Lange, W., Kempmann, A., Maybeck, V., Günther, A., Gruteser, N., Baumann, A., & Offenhäusser, A. (2016) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2016.07.001 · Cited by 22
CRISPR to the Rescue: Advances in Gene Editing for the FMR1 Gene
Yrigollen, C. M., & Davidson, B. L. (2019) · Brain Sciences · doi:10.3390/brainsci9010017 · Cited by 22
“Together with AAV9, AAV1, AAV2, AAV5 and AAV8 have been reported to express transgenes throughout the brain [54,55].”
BackgroundMaturana, C. J., Verpeut, J. L., Pisano, T. J., Dhanerawala, Z. M., Esteves, A. D., Enquist, L. W., & Engel, E. A. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.04.004 · Cited by 21
“AAV tropism is determined primarily by interactions between the capsid and specific receptors in susceptible and permissive cells.(3,4) However, the promoter sequence and other sequences included in the vector such as the inverted terminal repeat (ITR) sequence can have a substantial impact on tropism.”
BackgroundThe organization of cholinergic projections in the visual thalamus of the mouse
Sokhadze, G. E., Whyland, K. L., Bickford, M. E., & Guido, W. (2021) · The Journal of Comparative Neurology · doi:10.1002/cne.25235 · Cited by 21
“Such discrepancy could be due to our inability to make sufficiently large tracer injections to cover the full extent of PPTg, or the relatively low efficiency of viral labeling tech- niques compared to immunohistochemistry or other conventional tracers (Aschauer et al., 2013; Conte et al., 2009).”
BackgroundSchober, A. L., Gagarkin, D. A., Chen, Y., Gao, G., Jacobson, L., & Mongin, A. A. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00262 · Cited by 20
Cherif, K., Gérard, C., Rousseau, J., Ouellet, D. L., Chapdelaine, P., & Tremblay, J. P. (2018) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2018.04.009 · Cited by 19
Perez‐Rosello, T., Gelman, S., Tombaugh, G. C., Cachope, R., Beaumont, V., & Surmeier, D. J. (2019) · Movement Disorders · doi:10.1002/mds.27622 · Cited by 20
“Enhanced Yellow Fluorescent Protein expression was considered significant if the pixel fluorescence was 5 standard deviations above the background fluorescence.(23)”
BackgroundMartínez-Rivera, F. J., Pérez-Torres, J., Velázquez-Díaz, C. D., Sanchez-Navarro, M. J., Huertas-Pérez, C. I., Diehl, M. M., Phillips, M. L., Haber, S. N., & Quirk, G. J. (2022) · Biological Psychiatry · doi:10.1016/j.biopsych.2022.02.008 · Cited by 20
Liu, S., Chowdhury, E. A., Xu, V., Jerez, A., Mahmood, L., Ly, B. Q., Le, H. K., Nguyen, A., Rajwade, A., Meno‐Tetang, G. M. L., et al. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.10.005 · Cited by 19
Multiparametric Assays for Accelerating Early Drug Discovery
Herholt, A., Galinski, S., Geyer, P. E., Rossner, M. J., & Wehr, M. C. (2020) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2020.02.005 · Cited by 21
Diving into the brain: deep-brain imaging techniques in conscious animals
Campos, P., Walker, J. J., & Mollard, P. (2020) · Journal of Endocrinology · doi:10.1530/joe-20-0028 · Cited by 18
Jara, J. H., Stanford, M. J., Zhu, Y., Tu, M., Hauswirth, W. W., Bohn, M. C., DeVries, S. H., & Özdinler, P. H. (2015) · Gene Therapy · doi:10.1038/gt.2015.112 · Cited by 18
“A more recent and comprehensive analysis in the auditory cortex suggested that in addition to robust neuronal transduction, small numbers of astrocytes, microglia, and oligodendrocytes are also transduced by a distinct set of AAV serotypes (45).”
Jollé, C., Déglon, N., Pythoud, C., Bouzier‐Sore, A., & Pellerin, L. (2019) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2019.00201 · Cited by 19
“Usually, viral vectors derived from either lenti- or adeno-associated viruses exhibit a preferential tropism toward either neurons or astrocytes (Wu et al., 2006; Aschauer et al., 2013).”
BackgroundResultExploring two-photon optogenetics beyond 1100 nm for specific and effective all-optical physiology
Fu, T., Arnoux, I., Döring, J., Backhaus, H., Watari, H., Stasevičius, I., Fan, W., & Stroh, A. (2021) · iScience · doi:10.1016/j.isci.2021.102184 · Cited by 23
Selectively Imaging Cranial Sensory Ganglion Neurons Using AAV-PHP.S
Asencor, A. I., Dvoryanchikov, G. A., Makhoul, V., Tsoulfas, P., & Chaudhari, N. (2022) · eNeuro · doi:10.1523/eneuro.0373-21.2022 · Cited by 18
“This is comparable to the maximum frequency seen May/June 2022, 9(3) ENEURO.0373-21.2022 eNeuro.org for most in vivo transduction by AAV (Aschauer et al., 2013).”
BackgroundResultInfluentialLi, T., Li, D., Wei, Q., Shi, M., Xiang, J., Gao, R., Chen, C., & Xu, Z. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106114 · Cited by 19
Protracted CLN3 Batten disease in mice that genetically model an exon-skipping therapeutic approach
Centa, J. L., Stratton, M. P., Pratt, M. A., Oltmanns, J. R. O., Wallace, D. G., Miller, S. A., Weimer, J. M., & Hastings, M. L. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.05.025 · Cited by 19
“Additionally, while the use of the scAAV9 serotype is attractive due to its ability to cross the blood-brain barrier, this serotype is ineffective at transducing microglia.(59,60) SSOs avoid some of these challenges in that they target and corrects endogenous CLN3 expression and SSOs are taken up broadly across the CN…”
BackgroundMatsuzaki, Y., Fukai, Y., Konno, A., & Hirai, H. (2024) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2024.101337 · Cited by 18
“Although the tropism of different adeno-associated virus (AAV) vector serotype capsids has been studied in rodents, 7 – 11 there are only a few studies in non-human primates, 11 – 13 probably due to the limited number of animals available.”
Xiao, K., Sun, Z., Jin, X., Ma, W., Song, Y., Lai, S., Qian, C., Fan, M., Zhang, J., Yue, W., et al. (2018) · The Journal of Physiology · doi:10.1113/jp275970 · Cited by 19
“AAV serotype 9 was used in the experiment, since previous experiments showed that AAV9 has the highest transduction rate in hippocampus (Aschauer et al. 2013).”
MethodDistinct Cell-specific Roles of NOX2 and MyD88 in Epileptogenesis
de Almeida, C. A. S., Pongilio, R. P., Móvio, M. I., Higa, G. S. V., Resende, R. R., Jiang, J., Kinjo, É. R., & Kihara, A. H. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.926776 · Cited by 17
“, 2017) and AAV9 (Aschauer et al., 2013) are best suitable for neurons.”
BackgroundKofoed, R. H., Noseworthy, K., Wu, K., Sivadas, S., Stanek, L. M., Elmer, B. M., Hynynen, K., Shihabuddin, L. S., & Aubert, I. (2022) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2022.09.011 · Cited by 18
“In addition, AAV9 leads to higher gene delivery to cells in the brain following intracranial injections compared with most other natural serotypes, and we have observed a similar tendency following MRIgFUS-mediated delivery.(30,39,40) Compared with AAV9, AAV2HBKO resulted in a 2- to 7-fold higher percentage of transge…”
BackgroundWatson, Z. L., Ertel, M. K., Lewin, A. S., Tuli, S. S., Schultz, G. S., Neumann, D. M., & Bloom, D. C. (2016) · Journal of Virology · doi:10.1128/jvi.01028-16 · Cited by 18
“Ganglionic neurons detect a wide variety of sensory inputs, including temperature, touch, and pain, and relay this information into the central nervous system (CNS).”
BackgroundMoreno, C. L., Yang, L. C., Dacks, P. A., Isoda, F., van Deursen, J. M. A., & Mobbs, C. V. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166381 · Cited by 17
“Furthermore, several studies appear to produce expression levels comparable to those we demonstrated with the AAV2/8 serotype [15,43].”
Hughes, M., Nelvagal, H., Coombe-Tennant, O., Smith, D., Smith, C., Massaro, G., Poupon-Bejuit, L., Platt, F., & Rahim, A. (2023) · Cells · doi:10.3390/cells12121619 · Cited by 16
Menendez, C. M., Zuccolo, J., Swedo, S. E., Reim, S., Richmand, B. J., Ben‐Pazi, H., Kovoor, A., & Cunningham, M. W. (2024) · JCI Insight · doi:10.1172/jci.insight.164762 · Cited by 18
“Thus, we hypothesize that excess dopamine induced by AAb-mediated D2R signaling would influence D1R and sensitivity to dopamine in disease.”
InfluentialOptogenetic stimulation of the dorsal striatum bidirectionally controls seizures
Hyder, S. K., Lazarini-Lopes, W., Toib, J., Williams, G., Sukharev, A., & Forcelli, P. A. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2419178122 · Cited by 16
“1 C shows a representative case injected with AAV8 - CAG - ArchT - GFP for inhibition experiments and Fig.”
InfluentialRghei, A. D., Stevens, B. A. Y., Thomas, S. P., Yates, J. G. E., McLeod, B. M., Karimi, K., Susta, L., Bridle, B. W., & Wootton, S. K. (2021) · Journal of Visualized Experiments · doi:10.3791/62727 · Cited by 18
AAV13 Enables Precise Targeting of Local Neural Populations
Han, Z., Luo, N., Wu, Y., Kou, J., Ma, W., Yang, X., Cai, Y., Ma, L., Han, L., Wang, X., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232112806 · Cited by 16
Elina, K. C., Islam, J., Kim, H. K., & Park, Y. S. (2023) · The Journal of Headache and Pain · doi:10.1186/s10194-023-01669-z · Cited by 19
“By deducting the area of the selected cell*mean background fluorescence values from the integrated density, the fluorescent intensity or corrected total cell fluorescence was determined [33].”
Background吴诗昊, Wu, S., 廖志星, Rizak, J. D., 郑娜, 张琳恒, 谭恒, 何晓斌, 吴阳, 何夏萍, et al. (2017) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2017.015 · Cited by 16
“Although lentiviral and AAV vectors are the most attractive genetic manipulation tools in developing transgenic models, their application has been primarily restricted to rodents (Aschauer et al., 2013; Weinberg et al., 2013), with many mature transgenic rodent models used in fundamental research and clinical trials (…”
BackgroundInhibitory designer receptors aggravate memory loss in a mouse model of down syndrome
Hamlett, E. D., Ledreux, A., Gilmore, A., Vazey, E. M., Aston‐Jones, G., Boger, H. A., Paredes, D., & Granholm, A. (2019) · Neurobiology of Disease · doi:10.1016/j.nbd.2019.104616 · Cited by 16
“All vectors were cloned and packaged at the Penn Vector Core (University of Pennsylvania, Philadelphia, PA) specifically with AAV2/9 serotype to promote efficient transduction of neurons (Aschauer et al., 2013).”
Synaptic Integration of Thalamic and Limbic Inputs in Rodent Gustatory Cortex
Stone, M. E., Fontanini, A., & Maffei, A. (2020) · eNeuro · doi:10.1523/eneuro.0199-19.2019 · Cited by 16
“The AAV9 subtype was chosen for its preferred anterograde transport (Aschauer et al., 2013).”
Viral alpha-synuclein knockdown prevents spreading synucleinopathy
Menon, S. A., Kofoed, R. H., Nabbouh, F., Xhima, K., Al-Fahoum, Y., Langman, T., Mount, H. T. J., Shihabuddin, L. S., Sardi, S. P., Fraser, P. E., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab247 · Cited by 17
The metabolic signaling of the nucleoredoxin-like 2 gene supports brain function
Jaillard, C., Ouechtati, F., Clérin, E., Millet-Puel, G., Corsi, M., Aït-Ali, N., Blond, F., Chevy, Q., Gales, L., Farinelli, M., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102198 · Cited by 16
“5C) [59].”
Medina, C. A., Vargas, E., Munger, S. J., & Miller, J. E. (2022) · PLoS ONE · doi:10.1371/journal.pone.0265604 · Cited by 16
“Previous reports in rats suggest that retrograde transport of AAVs, including AAV5, from processes to cell body can occur [76], however, it is unclear whether this happens in our PD finch model.”
BackgroundMelin, E., Andersson, M., Gøtzsche, C. R., Wickham, J., Huang, Y., Szczygieł, J. A., Boender, A., Christiansen, S. H., Pinborg, L. H., Woldbye, D. P. D., et al. (2023) · Gene Therapy · doi:10.1038/s41434-023-00399-w · Cited by 15
“The AAV1, AAV2 and AAV8 serotypes have been reported to achieve effective delivery of transgenes into the hippocampal cells [27].”
Vogt, J., Kirischuk, S., Unichenko, P., Schlüter, L., Pelosi, A., Endle, H., Yang, J., Schmarowski, N., Cheng, J., Thalman, C., et al. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw370 · Cited by 17
“In line with recent data (Aschauer et al. 2013), we did not see differences in infection efficiency between these 2 AAV serotypes.”
A Molecular Reporter for Monitoring Autophagic Flux in Nervous System In Vivo
Castillo, K., Valenzuela, V., Oñate, M., & Hetz, C. A. (2016) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2016.09.077 · Cited by 16
Xiang, H., Xu, H., Fan, F., Shin, S., Hogan, Q. H., & Yu, H. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24183 · Cited by 15
Rajamani, K. T., Leithead, A. B., Kim, M., Barbier, M., Peruggia, M., Niblo, K., Barteczko, L., Lefèvre, A., Grinevich, V., & Harony‐Nicolas, H. (2021) · Scientific Reports · doi:10.1038/s41598-021-01818-x · Cited by 18
Paß, T., Ricke, K. M., Hofmann, P., Chowdhury, S. R., Nie, Y., Chinnery, P. F., Endepols, H., Neumaier, B., Carvalho, A. F., Rigoux, L., et al. (2024) · Brain · doi:10.1093/brain/awae089 · Cited by 15
Viral delivery of L1CAM promotes axonal extensions by embryonic cerebral grafts in mouse brain
Tsuchimochi, R., Yamagami, K., Kubo, N., Amimoto, N., Raudzus, F., Samata, B., Kikuchi, T., Doi, D., Yoshimoto, K., Mihara, A., et al. (2023) · Stem Cell Reports · doi:10.1016/j.stemcr.2023.02.012 · Cited by 15
“Among these, AAV9 has been reported to have the highest efficiency of gene transfer to cortical neurons in mouse brain when administered directly (Aschauer et al., 2013).”
BackgroundAebischer, M. K., Bouvarel, T., Barrozo, E., Kochardt, D., Elger, C., Haindl, M., Ruppert, R., Guillarme, D., & D’Atri, V. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108503 · Cited by 16
Peña‐Ortega, F. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160928151546 · Cited by 18
“011] [PMID: 15939236] [323] Aschauer, D.”
Kramer, P. R., Stinson, C., Umorin, M., Deng, M., Rao, M., Bellinger, L. L., Yee, M. B., & Kinchington, P. R. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.05.030 · Cited by 15
“Importantly, upon sectioning the brain no fluorescent signal was observed in the somatosensory cortex, a region projecting to the thalamus, supporting the idea that virus did not transport from the injection site to effect other brain nuclei resulting in our observed response but caution must be taken as the AAV5 and…”
BackgroundExpression of P301L-hTau in mouse MEC induces hippocampus-dependent memory deficit
Liu, X., Zeng, K., Li, M., Wang, Q., Liu, R., Zhang, B., Wang, J., Shu, X., & Wang, X. (2017) · Scientific Reports · doi:10.1038/s41598-017-04305-4 · Cited by 15
Guerrero, D. K. R., Donnett, J. G., Csicsvari, J., & Kovács, K. A. (2018) · eNeuro · doi:10.1523/eneuro.0087-18.2018 · Cited by 16
“Therefore, it was ideal to have constant levels of the optogenetic actuator protein without having to wait for the ramping up of the AAV-mediated viral expression that can typically take weeks (Aschauer et al., 2013).”
BackgroundA Simple, Two-Step, Small-Scale Purification of Recombinant Adeno-Associated Viruses
Chen, S., Papaneri, A. B., Walker, M., Scappini, E., Keys, R. D., & Martin, N. P. (2020) · Journal of Virological Methods · doi:10.1016/j.jviromet.2020.113863 · Cited by 15
Hippocampal GAD67 Transduction Using rAAV8 Regulates Epileptogenesis in EL Mice
Shimazaki, K., Kobari, T., Oguro, K., Yokota, H., Kasahara, Y., Murashima, Y. L., Watanabe, E., Kawai, K., & Okada, T. (2019) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2018.12.012 · Cited by 15
Ceccarelli, I., Fiengo, P., Remelli, R., Miragliotta, V., Rossini, L., Biotti, I., Cappelli, A., Petricca, L., Rosa, S. L., Caricasole, A., et al. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.11.019 · Cited by 16
“The AAV9 serotypewas chosen for its ability to infect neuronal cells (Aschauer et al., 2013; Huda et al., 2014), as also confirmed through in house experiments with several AAV serotypes (data not shown).”
Yu, Y., Weiss, R. M., & Wei, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1032434 · Cited by 16
“Since AAV9 was reported to target both neurons and glial cells (Aschauer et al., 2013; Dashkoff et al., 2016), it is believed that the expression of IL-17RA in all these brain-resident cells in PVN would be reduced by IL17RA siRNA.”
BackgroundTurco, F., Wegelius, A., Lind, O., Norrman, N., Magnusson, A.-C., Sund-Lundström, C., Norén, B., Hedberg, J. J., & Palmgren, R. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.07.010 · Cited by 14
Chen, T., Liu, W.-B., Zhu, S.-J., Aji, A., Zhang, C., Zhang, C.-C., Duan, Y., Zuo, J., Liu, Z.-C., Li, H., et al. (2024) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2409443121 · Cited by 15
“Moreover, AAV9 tends to achieve higher expression levels in inhibitory neurons compared to AAV2 ( 26 ).”
Genetics‐Based Targeting Strategies for Precise Neuromodulation
He, Y., Wei, Z., Xu, J., Jin, F., Li, T., Qian, L., Ma, J., Zheng, W., Javanmardi, N., Wang, T., et al. (2025) · Advanced Science · doi:10.1002/advs.202413817 · Cited by 13
Viral vectors as a promising nanotherapeutic approach against neurodegenerative disorders
Srivastava, V., Singh, A., Jain, G. K., Ahmad, F. J., Shukla, R., & Kesharwani, P. (2021) · Process Biochemistry · doi:10.1016/j.procbio.2021.07.002 · Cited by 13
Transneuronal tracing to map connectivity in injured and transplanted spinal networks
Fortino, T. A., Randelman, M. L., Hall, A. A., Singh, J., Bloom, D. C., Engel, E. A., Hoh, D. J., Hou, S., Zholudeva, L. V., & Lane, M. A. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.113990 · Cited by 15
MITA oligomerization upon viral infection is dependent on its N-glycosylation mediated by DDOST
Tu, Y., Yin, X., Liu, Q., Zhang, S., Wang, J., Ji, B., Zhang, J., Sun, M., Yang, Y., Wang, C.-H., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010989 · Cited by 14
“The AAV particles were purified as described previously [53].”
Method
Metadata
- Authors
- Aschauer, D. F., Kreuz, S., & Rumpel, S.
- Affiliations
- Research Institute of Molecular Pathology (AT)
- Boehringer Ingelheim (Germany) (DE)
- Corresponding author
- Rumpel, Simon
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-09-27
- Volume
- 8
- Issue
- 9
- Pages
- e76310
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3785459
- OpenAlex
- W2015741711
- Cited by
- 522
- References
- 68
- Citations by year
- 2026: 26 · 2025: 31 · 2024: 47 · 2023: 44 · 2022: 40 · 2021: 49 · 2020: 44 · 2019: 57 · 2018: 45 · 2017: 42 · 2016: 42 · 2015: 34 · 2014: 20 · 2013: 1
- FWCI
- 21.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Keywords
- adeno-associated virus vectors, AAV serotypes, AAV1, AAV2, AAV5, AAV6, AAV8, AAV9, transduction efficiency, axonal transport, retrograde transport, self-complementary AAV, gene delivery to the brain, striatum, hippocampus, neocortex, astrocytes, cortical neurons, microglia, oligodendrocytes, entorhinal cortex, dentate gyrus, reporter gene expression
- MeSH terms
- Dependovirus, Analysis of Variance, Animals, Axonal Transport, Brain, Cloning, Molecular, Gene Expression Regulation, Genetic Vectors, Microscopy, Fluorescence, Organ Specificity, Transduction, Genetic, Gene Transfer Techniques, Transgenes, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.